$3.5MSeed, 30 October 2025
Moves the ADPKD program toward IND-enabling studies and expands the pipeline.
- Amount
- $3.5M
- Stage
- Seed
- Announced
- 30 October 2025
- Lead
- pi Ventures
- Other investors
- Bluehill Capital, SOSV
- Use of funds
- Moves the ADPKD program toward IND-enabling studies and expands the pipeline.
- Checked
- Announced by the company
- Sources
- Helex Raises $3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases - Business Wir businesswire.com
Helex Raises $3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases - Business Wir Business Wir
Helex Raises $3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases - Business Wir inc42.com